Table 1 Patient characteristics in the prostate cancer bone metastases and spinal and pelvic osteoarthritis groups
From: Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases
Bone Metastases Group (n = 26) | Osteoarthritis Group (n = 13) | P-value | |
|---|---|---|---|
Age (years) | 74 ± 10 | 70 ± 15 | 0.68 |
BMI (kg/m2) | 25.6 ± 4.9 | 25 ± 3.2 | 0.87 |
Creatinine level (μmol/L) | 92.3 ± 27.4 | 96.1 ± 33.3 | 0.66 |
Time interval between injection and xSPECT imaging (min) | 215 ± 54 | 230 ± 50 | 0.32 |
SUVmean lumbar vertebrae | 6.7 ± 1.9 | 7.3 ± 1.9 | 0.26 |
SUVmax lumbar vertebrae | 8.6 ± 2.4 | 9.2 ± 2.1 | 0.35 |